Effects of tobacco smoking on pulmonary function indices among undergraduate students

Babatunde O. A. Adegoke; Ayodele Akintunde AKINREMI; Adekemi E Akintobi

doi:10.34058/njmr.v18i1.107

Babatunde O. A. Adegoke
Ayodele Akintunde AKINREMI Department of Physiotherapy, College of Medicine, University of Ibadan, Ibadan, Nigeria
Adekemi E Akintobi

DOI: https://doi.org/10.34058/njmr.v18i1.107

Keywords: Tobacco smoking, undergraduates, pulmonary function indices

Abstract

Background: Tobacco smoking is a risk factor for chronic respiratory disorders. The tobacco epidemic is driven by adolescents and young adults. Tobacco-related morbidity rises with increasing years of smoking, and the increasing number of young smokers may have considerable future public health implications.

Objective: This study investigated the effect of tobacco smoking on pulmonary function indices among undergraduate students.

Methods: This is a cross sectional study involving 104 male undergraduate students between 18 and 30 years of age. They were recruited by snowball sampling and were grouped based on their smoking status (current smoker 52: non-smoker 52). Participants with signs of respiratory disease, thoracic spine deformity, or contraindication to spirometry were excluded from the study. Participants’ forced vital capacity (FVC), forced expiratory volume in first second (FEV1), both in litres, and forced expiratory ratio (FER) in percentage were assessed using standard protocols. Data were analyzed using mean, standard deviation, independent t-test and chi-square test with alpha level set at 0.05.

Results: The two groups were not significantly different in age, height and body mass index (BMI). Smokers had significantly reduced FVC (3.42±0.42 vs 3.87±0.4 litres) p=0.03; FEV1 (2.39±0.37 vs 3.22±0.38 litres) p=0.001 and FER (%) (70.7±7.58vs82.3±4.05) p=0.01. Among the smokers, a relationship was observed between years and numbers of cigarettes smoked and lung function. The proportion of participants with FER below the age-matched reference was significantly higher among smokers than non-smokers (40.4%vs6.7%) at p=0.021.

Conclusion: Smoking reduced pulmonary function among undergraduate students. This may have important public health implications since continued smoking may accelerate lung function deterioration and consequently increase the future risk of developing lung disease.

References

Abbasi NI, Ahsan A. and Nafees AA. Correlation of respiratory symptoms and spirometric lung patterns in a rural community setting, Sindh, Pakistan: a cross sectional survey. BMC Pulmonary Medicine. 2012. 12:81

Bohadana AB, Nilsson F, Westin A, Martinet N and Martinet Y. Smoking cessation - but not smoking reduction - improves the annual decline in FEV1 in occupationally exposed workers. Respir Med 2006. 100: 1423-30.

Cerveri I, Accordini S and Verlato G. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J. 2001; 18:85–92.

Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, Spears M, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med. 2006; 174: 127-33.

Enright PL, Connettw JE and Bailey WC. The FEV1/FEV6 Predicts Lung Function Decline In Adult Smokers. Respiratory Medicine. 2002; 96: 444 - 449

Isabel U, Alberto C, María QJ, Nerea M, Xavier B, Jordi S. Smoking habit, respiratory symptoms and lung function in young adults. Eur J Public Health. 2005; 15: 160-5.

Jha P. Avoidable global cancer deaths and total deaths from smoking. Nature Reviews: Cancer. 2009; (9):655-664.

Mathers CD and Loncar D. “Projections of global mortality and burden of disease from 2002 to 2030,” PLoS Medicine, 2006. 3(11): article e442

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005; 26: 319-38.

National Heart, Lung, and Blood Institute: Guidelines for the Diagnosis and Management of Asthma, National Asthma Education and Prevention Program of the National Heart, Lung and Blood Institute, Expert Panel Report 3, 2007.

Nnodu OE and Jamda MA. Assessment of cigarette smoking pattern and sources of negative influences that drive it among students of the University of Abuja, Nigeria. 2006

Parkes G, Greenhalgh T, Griffin M and Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008; 336: 598-600.

Prasad BK, Sahay AP and Singh AK, Smoking women and their lung function tests. Kathmandu University Medical Journal. 2003; 2(6): 142-144.

Rasmussen SR, Prescott E, Sorensen TI, Sogaard J. The total lifetime health cost savings of smoking cessation to society. Eur J Public Health. 2005; 15: 601-6.

Townsend L, Flisher AJ, Gilreath T and King G: A systematic review of tobacco use among sub-Saharan Africa youth. Journal of Substance Use. 2006; 11(4):245-269.

Urrutia I, Capelastegui A, Quintana J, Mun˜ iozguren N, Basagana X, Sunyer J and the Spanish Group of the European Community Respiratory Health Survey (ECRHS–I). Smoking habit, respiratory symptoms and lung function in young adults. European Journal of Public Health. 2005; 15(2): 160–165

World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. WHO, Geneva, 1998; 76-101.

World Health Organization. Report on the Global Tobacco Epidemic, 2011: The MPOWER package. Geneva: World Health Organization; 2011.